Joy Artin et al. 2023. Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. Archives of Rheumatology. 38, 2 (Jun. 2023), 249–256. DOI:https://doi.org/10.46497/ArchRheumatol.2023.9638.